Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects

This study has been completed.
Information provided by:
Novo Nordisk A/S Identifier:
First received: February 2, 2012
Last updated: NA
Last verified: February 2012
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2002
  Primary Completion Date: December 2002 (Final data collection date for primary outcome measure)